BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2303364)

  • 21. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation.
    Baumann M; DuBois W; Pu A; Freeman J; Suit HD
    Int J Radiat Oncol Biol Phys; 1992; 23(4):803-9. PubMed ID: 1319979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: x-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo.
    Leith JT; Quaranto L; Padfield G; Michelson S; Hercbergs A
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):283-7. PubMed ID: 8420876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
    Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation.
    Dahlberg WK; Azzam EI; Yu Y; Little JB
    Cancer Res; 1999 Oct; 59(20):5365-9. PubMed ID: 10537321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
    Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
    Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
    Akimoto T; Seong J; Hunter NR; Buchmiller L; Mason K; Milas L
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):413-9. PubMed ID: 10760438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherent radiosensitivity and split-dose recovery in plateau-phase cultures of 10 human tumour cell lines.
    Courdi A; Bensadoun RJ; Gioanni J; Caldani C
    Radiother Oncol; 1992 Jun; 24(2):102-7. PubMed ID: 1496140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Time factor and repopulation during fractionated radiotherapy. Comparison between two xenografted human squamous cell carcinoma].
    Hesselmann S; Lindel K; Horn K; Könemann S; Schuck A; Willich N; Rübe C
    Strahlenther Onkol; 2003 Jan; 179(1):38-44. PubMed ID: 12540983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Might intrinsic radioresistance of human tumour cells be induced by radiation?
    Lambin P; Malaise EP; Joiner MC
    Int J Radiat Biol; 1996 Mar; 69(3):279-90. PubMed ID: 8613677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substructure in the radiation survival response at low dose in cells of human tumor cell lines.
    Skarsgard LD; Skwarchuk MW; Wouters BG; Durand RE
    Radiat Res; 1996 Oct; 146(4):388-98. PubMed ID: 8927711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons.
    Warenius HM; Britten RA; Browning PG; Morton IE; Peacock JH
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):913-20. PubMed ID: 8138445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
    Wilkins RC; Ng CE; Raaphorst GP
    Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity.
    Rofstad EK; Brustad T
    Br J Cancer; 1985 Feb; 51(2):201-10. PubMed ID: 3966977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublethal damage repair in two radioresistant human tumor cell lines irradiated as multicellular spheroids.
    Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
    Tumour Biol; 1991; 12(4):207-16. PubMed ID: 1871510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local tumor control following single dose irradiation of human melanoma xenografts: relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse.
    Rofstad EK
    Cancer Res; 1989 Jun; 49(12):3163-7. PubMed ID: 2655893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrimination of human tumor radioresponsiveness using low-dose rate irradiation.
    Björk-Eriksson T; West C; Karlsson E; Mercke C
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1147-53. PubMed ID: 9869242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report.
    Suit HD; Zietman A; Tomkinson K; Ramsay J; Gerweck L; Sedlacek R
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):365-73. PubMed ID: 2154419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiobiologic effect of intermittent radiation exposure in murine tumors.
    Sugie C; Shibamoto Y; Ito M; Ogino H; Miyamoto A; Fukaya N; Niimi H; Hashizume T
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):619-24. PubMed ID: 16414375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between radiosensitivity and repair of potentially lethal damage in human tumor cell lines with implications for radioresponsiveness.
    Deschavanne PJ; Fertil B; Chavaudra N; Malaise EP
    Radiat Res; 1990 Apr; 122(1):29-37. PubMed ID: 2320723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data.
    Malaise EP; Fertil B; Chavaudra N; Guichard M
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):617-24. PubMed ID: 3009370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.